Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Hypertension. 2019 May;73(5):1025–1035. doi: 10.1161/HYPERTENSIONAHA.118.12462

Table 3.

MSNA and cardiovascular variables at baseline and during lower body negative pressure (LBNP)

Stimulus 2-way RM ANOVA P-value

Variable Group Baseline LBNP −15 LBNP −30 Group Time point Interaction
MSNA, bursts·min−1 YG (n=12) 10 ± 1 15 ± 2 22 ± 3 0.004 <0.001 0.237
MA/O (n=10) 25 ± 4 30 ± 4 33 ± 5

MSNA, bursts·100hb−1 YG (n=12) 17 ± 2 24 ± 3 32 ± 5 <0.001 <0.001 0.280
MA/O (n=10) 45 ± 7 53 ± 7 57 ± 8

MSNA, AU·min−1 YG (n=12) 490 ± 66 780 ± 101 1317 ± 293 0.021 <0.001 0.655
MA/O (n=10) 1180 ± 221 1611 ± 233 1871 ± 408

Norepinephrine, pg·mL−1 YG (n=12) 211 ± 34 221 ± 20 306 ± 37 <0.001 <0.001 0.003
MA/O (n=13) 298 ± 34 552 ± 47* 598 ± 68*

Systolic BP, mmHg YG (n=15) 113 ± 2 112 ± 3 112 ± 3 0.520 <0.001 0.135
MA/O (n=14) 117 ± 3 117 ± 4 112 ± 4

Diastolic BP, mmHg YG (n=15) 68 ± 1 68 ± 1 71 ± 1* 0.165 0.272 0.049
MA/O (n=14) 73 ± 2 73 ± 3 72 ± 3

Mean BP, mmHg YG (n=15) 83 ± 1 83 ± 2 84 ± 2 0.248 0.722 0.038
MA/O (n=14) 88 ± 2 88 ± 3 86 ± 3

Heart rate, beats·min−1 YG (n=15) 59 ± 2 61 ± 2 68 ± 3# 0.028 <0.001 0.021
MA/O (n=14) 54 ± 2 55 ± 3 58 ± 3#

Values are means ± SE. YG, young adults; MA/O, middle-age/older adults; MSNA, muscle sympathetic nerve activity; AU, arbitrary units; BP, arterial blood pressure;

*

P<0.05 vs. baseline,

#

P<0.05 vs. baseline and LBNP −15mmHg;

P<0.05 vs. YG; Holm-Sidak post hoc did not detect significant differences between YG and MA/O in mean BP during LBNP despite 2-way RM ANOVA significant interaction.